ChemicalBook > CAS DataBase List > Utomilumab
Utomilumab
- Product Name
- Utomilumab
- CAS No.
- 1417318-27-4
- Chemical Name
- Utomilumab
- Synonyms
- Utomilumab;PF 05082566|||PF-2566;Utomilumab (anti-TNFRSF9);Research Grade Utomilumab;Research Grade Utomilumab (DHG11001)
- CBNumber
- CB68081003
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Utomilumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Utomilumab Chemical Properties,Usage,Production
Uses
Utomilumab is a fully human IgG2 monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical anti-tumour activity.
in vivo
Utomilumab (1-10 mg/kg) is well tolerated in the PBMC humanized mouse model[3].
IC 50
4-1BB
Utomilumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Utomilumab Suppliers
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 17721492509; 17721492509
- 643638326@qq.com
- Country
- China
- ProdList
- 4970
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
1417318-27-4, UtomilumabRelated Search:
Urelumab
varlilumab
Eptinezumab
Atezolizumab
Obinutuzumab
Sutimlimab
Glofitamab
Nesvacumab
Odronextamab
Rituximab